News

Dec 1

Starting HIV Meds Within a Year of Infection Helps Restore CD4s

Beginning antiretroviral (ARV) treatment for HIV within a year of the estimated date of seroconversion (EDS) improves the likelihood of returning an individual’s CD4 count to a normal level, provided CD4s are higher than 500 upon starting meds, Reuters reports. Publishing their findings in JAMA Internal Medicine, researchers analyzed data regarding 1,119 people from the ongoing U.S. Military HIV Natural ...
Read More
Nov 14

Successful treatments are helping HIV-infected persons achieve similar longevity as those without HIV

New research from the Johns Hopkins Bloomberg School of Public Health suggests that HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV. The findings appeared online last month in the ...
Read More
Oct 29

Elton John AIDS Foundation Invests in MSM, LGBT Programs

The Elton John AIDS Foundation is donating funds to new HIV programs focused on the U.S. LGBT population as well as on men who have sex with men (MSM) in South Africa, according to an EJAF press release. Sir Elton John and his partner David Furnish—the EJAF founder and chairman, respectively—met with Secretary of State John Kerry to ...
Read More
Oct 22

Social Security Announces 1.7 Percent Benefit Increase for 2015

Monthly Social Security and Supplemental Security Income (SSI) benefits for nearly 64 million Americans will increase 1.7 percent in 2015, the Social Security Administration announced today. The 1.7 percent cost-of-living adjustment (COLA) will begin with benefits that more than 58 million Social Security beneficiaries receive in January 2015. Increased payments to more than 8 million SSI beneficiaries will begin on December ...
Read More
Oct 17

'Wonder drug' which can reduce HIV risk by 92% could be offered on the NHS

An HIV 'wonder drug' could be made available on the NHS, in what has been hailed as the most significant breakthrough against the virus in a generation. A landmark trial in England is to be sped up after interim analysis of the the drug Truvada found it to be 'highly protective against HIV'. Campaigners have urged the NHS to offer the medication ...
Read More
Oct 8

People With HIV and Kidney Problems Should Avoid Viread (Tenofovir

While antiretroviral (ARV) therapy is beneficial for HIV-positive people with reduced kidney function, they should not take Viread (tenofovir), according to updated guidelines from the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA). Published in Clinical Infectious Diseases, the guidelines take into account the findings of large studies published since their last update in 2005. ...
Read More
Oct 7

Computers turned into powerful allies in fight against AIDS

Effective treatment of HIV-virus is a race against time: Many of the drugs that have been potent killers of HIV-virus, have today lost their power, because the virus has become resistant to them. As a result science must constantly develop new drugs that can attack the virus in new ways. Now researchers from the University of Southern Denmark present a method ...
Read More
Sep 17

CDC Launches HIV Treatment Awareness Campaign

“HIV Treatment Works” is a new awareness campaign from the U.S. Centers for Disease Control and Prevention (CDC).    The campaign promotes the benefits of care and treatment for people living with the virus and seeks to get more of them in care and on treatment. It is the latest campaign in the CDC Act Against AIDS initiative.    In addition to helping people ...
Read More
Sep 16

HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir

An investigational single-tablet combination regimen to treat HIV has comparable efficacy to and is less toxic than a similar regimen of individual tablets, thanks to the new form of tenofovir in the combo pill, MedPage Today reports. Reporting their findings at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC, researchers conducted a Phase II, placebo-controlled, randomized ...
Read More
Sep 9

Flu Shots Work for Pregnant Women Regardless of HIV Status

The influenza vaccine is just as effective for pregnant women living with HIV as for those without the virus, Reuters reports. Publishing their findings in The New England Journal of Medicine, researchers conducted double-blind, randomized, placebo-controlled trials in 2011 and 2012 with 2,237 pregnant women; 188 were HIV positive. After receiving either a flu shot or a placebo, the women, ...
Read More

Pages

Subscribe to News